Amiel C, Kusnierz J P, Mouton Y, Rook G, Stanford J, Singh M, Capron A, Bahr G M
Laboratory of Molecular Immunology of Infections and Inflammation, Institut Pasteur de Lille, France.
J Clin Immunol. 2000 Nov;20(6):458-65. doi: 10.1023/a:1026411916855.
Immunologic parameters, known to be grossly abnormal in HIV-1-infected subjects, were analyzed in 22 patients with sustained viral load suppression (<200 copies/ml) following long-term highly active antiretroviral therapy (HAART). Responses were compared with those from 18 HIV-seronegative healthy controls. Persistent phenotypic alterations in patients' blood mononuclear cells were minimal, though the percentages of lymphocytes that could be activated to produce interleukin-2 (IL-2) remained severely depressed. Using lymphoproliferative assays, a striking deficit in the capacity of patients to respond to the common mycobacterial antigens and particularly to recombinant heat-shock proteins paralleled the absence of responses to virus p24 antigen. In view of the important immunoregulatory role of stress proteins, these findings reveal profound functional deficiencies and persistent immune dysregulation in HIV-1 patients, despite successful HAART and a considerable recovery of CD4+ lymphocyte numbers. Rational immunotherapeutic approaches should be aimed to correct the characterized immune abnormalities.
在22例接受长期高效抗逆转录病毒治疗(HAART)后病毒载量持续抑制(<200拷贝/毫升)的患者中,分析了已知在HIV-1感染受试者中严重异常的免疫参数。将结果与18名HIV血清阴性健康对照者的结果进行比较。患者血液单核细胞中持续的表型改变很小,尽管可被激活产生白细胞介素-2(IL-2)的淋巴细胞百分比仍严重降低。使用淋巴细胞增殖试验,患者对常见分枝杆菌抗原尤其是重组热休克蛋白的反应能力存在显著缺陷,这与对病毒p24抗原无反应情况相似。鉴于应激蛋白具有重要的免疫调节作用,这些发现揭示了HIV-1患者尽管HAART治疗成功且CD4 +淋巴细胞数量有相当程度的恢复,但仍存在严重的功能缺陷和持续的免疫失调。合理的免疫治疗方法应旨在纠正所表征的免疫异常。